Shares of Moderna Inc. MRNA, -1.81% shed 1.81% to $169.61 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, +0.50% rising 0.50% to 14,417.55 and the Dow Jones Industrial Average DJIA, +0.63% rising 0.63% to 35,629.33. The stock’s fall snapped a three-day winning streak. Moderna Inc. closed $327.88 short of its 52-week high ($497.49), which the company achieved on August 10th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. ABBV, +1.18% rose 1.18% to $138.62, Amgen Inc. AMGN, +0.11% rose 0.11% to $228.93, and AstraZeneca PLC ADR AZN, +2.31% rose 2.31% to $59.01. Trading volume (5.3 M) remained 6.4 million below its 50-day average volume of 11.8 M.